These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19445713)

  • 21. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
    Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
    J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage site.
    Hou X; Yang W; Zhao Y; Agarwal A; Huang M
    Virology; 2009 Jan; 383(2):271-8. PubMed ID: 19036397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease.
    Tran HTL; Morikawa K; Anggakusuma ; Zibi R; Thi VLD; Penin F; Heim MH; Quadroni M; Pietschmann T; Gouttenoire J; Moradpour D
    PLoS One; 2020; 15(7):e0236447. PubMed ID: 32697788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation.
    Kammarabutr J; Mahalapbutr P; Nutho B; Kungwan N; Rungrotmongkol T
    J Mol Graph Model; 2019 Jun; 89():122-130. PubMed ID: 30884449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of proteolytic activity of hepatitis C virus NS3-4A protease using enzymelinked immunosorbent assay].
    Chen X; Guo J; Chen H; Wanglin
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):300-2. PubMed ID: 12903484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
    Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S
    J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
    Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
    Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the protease domain in NS3 of hepatitis C virus.
    Han DS; Hahm B; Rho HM; Jang SK
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():985-93. PubMed ID: 9049347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
    Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
    J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase.
    Yao N; Reichert P; Taremi SS; Prosise WW; Weber PC
    Structure; 1999 Nov; 7(11):1353-63. PubMed ID: 10574797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitors.
    Chowdhury AY; Tavis JE; George SL
    Virology; 2014 May; 456-457():300-9. PubMed ID: 24889249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity.
    Richer MJ; Juliano L; Hashimoto C; Jean F
    J Biol Chem; 2004 Mar; 279(11):10222-7. PubMed ID: 14701815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NS3-4A of hepatitis C virus is a chymotrypsin-like protease.
    Hahm B; Han DS; Back SH; Song OK; Cho MJ; Kim CJ; Shimotohno K; Jang SK
    J Virol; 1995 Apr; 69(4):2534-9. PubMed ID: 7884903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches.
    Ezat AA; Elshemey WM
    Life Sci; 2019 Jan; 217():176-184. PubMed ID: 30528183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.
    Pillaiyar T; Namasivayam V; Manickam M
    Curr Med Chem; 2016; 23(29):3404-3447. PubMed ID: 27160539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.